Imagion Biosystems Limited (IBXXF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.58 Million AUD | -54.03% |
| 2022 | 9.97 Million AUD | -29.33% |
| 2021 | 14.11 Million AUD | -0.03% |
| 2020 | 14.11 Million AUD | 189.79% |
| 2019 | 4.87 Million AUD | -6.08% |
| 2018 | 5.18 Million AUD | -32.11% |
| 2017 | 7.64 Million AUD | -37.07% |
| 2016 | 12.14 Million AUD | 1440.45% |
| 2015 | 788.18 Thousand AUD | 132.84% |
| 2014 | 338.5 Thousand AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 FY | 4.58 Million AUD | -54.03% |
| 2023 Q3 | 4.58 Million AUD | -19.06% |
| 2023 Q4 | 4.58 Million AUD | 0.0% |
| 2023 Q1 | 5.66 Million AUD | -43.2% |
| 2023 Q2 | 5.66 Million AUD | 0.0% |
| 2022 Q2 | 14.39 Million AUD | 0.0% |
| 2022 Q4 | 9.97 Million AUD | 0.0% |
| 2022 FY | 9.97 Million AUD | -29.33% |
| 2022 Q1 | 14.39 Million AUD | 1.95% |
| 2022 Q3 | 9.97 Million AUD | -30.68% |
| 2021 Q1 | 14.72 Million AUD | 4.29% |
| 2021 FY | 14.11 Million AUD | -0.03% |
| 2021 Q4 | 14.11 Million AUD | 0.0% |
| 2021 Q3 | 14.11 Million AUD | -4.14% |
| 2021 Q2 | 14.72 Million AUD | 0.0% |
| 2020 FY | 14.11 Million AUD | 189.79% |
| 2020 Q1 | 5.74 Million AUD | 17.84% |
| 2020 Q2 | 5.74 Million AUD | 0.0% |
| 2020 Q4 | 14.11 Million AUD | 0.0% |
| 2020 Q3 | 14.11 Million AUD | 145.93% |
| 2019 Q1 | 3.96 Million AUD | -23.61% |
| 2019 Q3 | 4.87 Million AUD | 22.95% |
| 2019 Q4 | 4.87 Million AUD | 0.0% |
| 2019 FY | 4.87 Million AUD | -6.08% |
| 2019 Q2 | 3.96 Million AUD | 0.0% |
| 2018 Q4 | 5.18 Million AUD | 0.0% |
| 2018 Q2 | 4.75 Million AUD | 0.0% |
| 2018 Q1 | 4.75 Million AUD | -37.75% |
| 2018 FY | 5.18 Million AUD | -32.11% |
| 2018 Q3 | 5.18 Million AUD | 9.06% |
| 2017 Q2 | 12.81 Million AUD | 0.0% |
| 2017 Q1 | 12.81 Million AUD | 0.0% |
| 2017 FY | 7.64 Million AUD | -37.07% |
| 2017 Q4 | 7.64 Million AUD | 0.0% |
| 2017 Q3 | 7.64 Million AUD | -40.35% |
| 2016 FY | 12.14 Million AUD | 1440.45% |
| 2015 FY | 788.18 Thousand AUD | 132.84% |
| 2014 FY | 338.5 Thousand AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -261.408% |
| Arrayit Corporation | 1 Million USD | -358.449% |
| Atlantic International Corp. | 4.43 Million USD | -3.379% |
| Biocept, Inc. | 30.87 Million USD | 85.145% |
| Bioqual, Inc. | 56.58 Million USD | 91.895% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -1877.421% |
| DermTech, Inc. | 121.93 Million USD | 96.239% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.89% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 74.202% |
| iMD Companies, Inc. | 190.13 Thousand USD | -2312.088% |
| IDenta Corp. | 1.52 Million USD | -199.898% |
| Interpace Biosciences, Inc. | 13.02 Million USD | 64.778% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | 44.422% |
| InVitro International | 1.53 Million USD | -198.973% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 82.911% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -198268.166% |
| Medical Imaging Corp. | 4.19 Million USD | -9.415% |
| NovelStem International Corp. | 2.25 Million USD | -103.423% |
| Optigenex Inc. | 1.88 Million USD | -142.88% |
| PharmChem, Inc. | 2.76 Million USD | -65.835% |
| Proteome Sciences plc | 14.58 Million USD | 68.557% |
| Response Genetics, Inc | 48.88 Million USD | 90.618% |
| Rennova Health, Inc. | 20.57 Million USD | 77.707% |
| RushNet, Inc. | 6.04 Million USD | 24.164% |
| ScreenPro Security Inc. | 1.26 Million USD | -263.598% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -870.798% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -554.572% |
| Todos Medical Ltd. | 15.26 Million USD | 69.96% |